Therapeutic Options for Treatment of Burning Mouth Syndrome
NCT04475614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2020-07-17
Summary
Burning mouth syndrome is a painful condition of unknown etiology that impairs the quality of life and does not have an adequate therapeutic option. The purpose of this study is to determine the most effective treatment option for burning mouth syndrome, among oral probiotics, low-level laser, B-vitamin injections and informative treatment only.
Conditions
- Burning Mouth Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
BioGaia Prodentis lozenges
oral probiotics
- PROCEDURE
-
low level laser treatment with Ga-Al-As laser
low level laser treatment
- DIETARY_SUPPLEMENT
-
B vitamin injections (Neurobion, Merck, Darmstadt, Germany)
intra muscular vitamin injections
Sponsors & Collaborators
-
University of Zagreb
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 39 Years
- Max Age
- 83 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-15
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- Croatia
Study Locations
More Related Trials
-
Effects of Photobiomodulation in Burning Mouth Syndrome
NCT04034849 ·Status: COMPLETED ·Phase: NA
-
Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
NCT05309681 ·Status: COMPLETED
-
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
NCT02580734 ·Status: COMPLETED ·Phase: NA
-
Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
NCT04313907 ·Status: UNKNOWN ·Phase: PHASE4
-
Burning Mouth Syndrome: Effects of Occlusal Splint Therapy
NCT07344909 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
NCT05729529 ·Status: UNKNOWN ·Phase: NA
-
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
NCT06217731 ·Status: COMPLETED ·Phase: NA
-
Alpha Lipoic Acid for Burning Mouth
NCT00387543 ·Status: COMPLETED
-
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
NCT05872789 ·Status: COMPLETED ·Phase: NA
-
Effect of Photobiomodulation for Patients With Xerostomia
NCT05336981 ·Status: COMPLETED ·Phase: NA
-
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
NCT06195137 ·Status: COMPLETED ·Phase: NA
-
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
NCT04535973 ·Status: COMPLETED
-
HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
NCT01931293 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
NCT04884503 ·Status: COMPLETED ·Phase: PHASE2
-
Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients
NCT06703372 ·Status: COMPLETED ·Phase: NA
-
A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
NCT00862576 ·Status: COMPLETED
-
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
NCT00504387 ·Status: UNKNOWN
-
Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary Metabolomics
NCT04704128 ·Status: COMPLETED
-
The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
NCT01754740 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601 ·Status: COMPLETED ·Phase: NA
-
Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era
NCT04434014 ·Status: UNKNOWN
-
CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA
NCT04719091 ·Status: COMPLETED ·Phase: NA
-
Duration of Effect of Biotene Spray in Patients With Dry Mouth
NCT03663231 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
NCT02690844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial
NCT05640362 ·Status: COMPLETED ·Phase: NA